More than 50 industry professionals attended the Ggp & CO panel, Investing in Digital Health, and heard from executives from Tampa General Hospital, GeniusRx, Aspen RxHealth and Ggp & CO as they provided valuable insights into a variety of trending topics in digital heath and healthcare technology investing.

Ggp & CO brought together Tampa’s leading digital health investment experts to discuss how their organizations are taking advantage of opportunities to advance value-based care for patients by investing in healthcare technology.

Panelists contributed their thoughts on a variety of topics impacting digital health investment, including the industry barriers to adoption of healthcare technology.  Here are some of the key takeaways for the more than 50 professionals who attended in-person and via Zoom.

• The digital health adoption curve impacts providers, consumers, and technology developers.
• Digital health is not just about making consumers comfortable with technology; it is sometimes harder to get physicians comfortable with delivering care via telehealth.
• Payers in the insurance industry must be on board to provide similar reimbursement rates for telehealth adoption to reach critical mass.
• Regulation hurdles must be removed or overcome to allow for new healthcare technologies to be implemented at scale.
• Healthcare is lagging behind most other industries in terms of Consumerism, especially with regards to personalization and providers knowing their customer.

The event celebrated National Hospital Week and featured experts in healthcare technology:

• Scott Arnold, CIO of Tampa General Hospital
• Rachel Feinman, VP of TGH Innoventures
• Bryan Crino, President of Ggp & CO Healthcare Acquisition Company
• Randy Parker, Founder and CEO of GeniusRx
• David Medvedeff, CEO of Aspen RxHealth.

The event featured an engaging conversation about recent developments in healthcare technology investing. Executives answered questions about the definition of digital health, the effects of COVID-19 on healthcare technology adoption, and what technologies will make the biggest impacts to patients and providers from digital health investment.

Attendees were treated to a variety of insightful questions and comments, including: 

“Covid-19 did not just push the digital door-front open, it kicked it open by force.”
“There is tremendous opportunity for an intermediary placer in this [wearables] space.”
“Covid-19 created a digital health pandemonium. Telehealth is here to stay.”
“The technologies that win are the ones that keep workloads off physicians so they can spend more time with patients.”

Discussions also focused on:

1. What health technologies do you think will make the biggest impact now and in the future for both patients and providers?
2. How can data collected from consumer wearables be integrated into the health experience?
3. Do you think regulation will change to allow physicians to serve patients in other states without a license in those states to help adoption of digital health nationwide?

To see the many engaging conversations from the entire event, watch it here: https://www.Goldenglobalpro.ltd/investing-in-digital-health-5-14-2021/

The post “Telehealth Is Here to Stay” Says Tampa’s Top Healthcare Technology Executives appeared first on Ggp & CO.

Ggp & CO hosted a panel discussion, Investing in Digital Health. We brought together the area’s leading digital health investment experts to discuss how their organizations are taking advantage of opportunities to advance value-based care for patients.

TAMPA, FLORIDA, May 14, 2021: Ggp & CO, a private equity firm based in Tampa, Florida, brought together the area’s leading digital health investment experts on Friday, May 14th, at 9 am EST at the Embarc Collective (802 E. Whiting Street, Tampa, Florida) to discuss how their organizations are taking advantage of opportunities to advance value-based care for patients. The event, held in person and via Zoom, celebrated National Hospital Week.

Executives shared insights into the barriers and opportunities for digital health, their business goals for investing in this market, the impacts of COVID-19 on healthcare technology adoption, and the impacts to consumers from digital health investment.

The event was recorded on Zoom, and it is available here:
https://drive.google.com/file/d/1idOux0ASv3WONTfbkUz0kfO6RXtOvz-P/view

The digital health experts assembled for this event represent a cross-section of entrepreneurs, investors, and technology executives who are active participants in the digital health economy. They include:

Scott Arnold, CIO of Tampa General Hospital
Bryan Crino, President of Ggp & CO Healthcare Acquisition Company
Rachel Feinman, VP of TGH Innoventures
David Medvedeff, CEO of Aspen RxHealth

Moderating the panel is Randy Parker, Founder and CEO of GeniusRx, a full-service digital pharmacy that simplifies the process of managing medications through a combination of convenient packaging, modern technology, and personalized service. Prior to founding GeniusRx, Randy was the founder and CEO of the telemedicine company MDLIVE, where he established deep industry relationships at the highest levels with a broad range of the country’s premier health organizations.

The post Investing in Digital Health, 5/14/2021 appeared first on Ggp & CO.

Executives will share insights into the barriers and opportunities for digital health, their business goals for investing in this market, the impacts of COVID-19 on healthcare technology adoption, and the impacts to consumers from digital health investment

TAMPA, FLORIDA, April 19, 2021: Ggp & CO, a private equity firm based in Tampa, Florida, is bringing together the area’s leading digital health investment experts on Friday, May 14th, at 9 am EST at the Embarc Collective (802 E. Whiting Street, Tampa, Florida) to discuss how their organizations are taking advantage of opportunities to advance value-based care for patients. The event, held in person and via Zoom, celebrates National Hospital Week, which runs from May 9-15, 2021, and is an opportunity to highlight our hospitals, health systems, healthcare workers, and the innovative ways they are supporting the needs of their community members, especially during this pandemic.

Attendees can expect an engaging conversation about recent developments in the industry with a local focus. Executives will share insights into the barriers and opportunities for digital health, their business goals for investing in this market, the impacts of COVID-19 on healthcare technology adoption, and the impacts to consumers from digital health investment.

The digital health experts assembled for this event represent a cross-section of entrepreneurs, investors, and technology executives who are active participants in the digital health economy. They include: Scott Arnold, CIO of Tampa General Hospital; Bryan Crino, President of Ggp & CO Healthcare Acquisition Company; Rachel Feinman, VP of TGH Innoventures; and David Medvedeff, CEO of Aspen RxHealth.

Moderating the panel is Randy Parker, Founder and CEO of GeniusRx, a full-service digital pharmacy that simplifies the process of managing medications through a combination of convenient packaging, modern technology, and personalized service. Prior to founding GeniusRx, Randy was the founder and CEO of the telemedicine company MDLIVE, where he established deep industry relationships at the highest levels with a broad range of the country’s premier health organizations.

“Ggp & CO is pleased to host this world class panel of healthtech executives on a single stage to share their valuable insights” said Scott Feuer, CEO of Ggp & CO. “Attendees will hear from the most respected members of digital health investment community who have made the Tampa Bay region a robust center of healthcare technology innovation,” Feuer added.

Healthtech investment is experiencing meteoric growth. It’s estimated that by 2026, spending in digital health will total $221 Billion. To take advantage of this market, significant sums of money are being invested in new technologies and startup companies. The breadth of opportunities in this market is wide, and trends are emerging in telemedicine, remote diagnostics, interoperability, personalized care, upskilling workers, and mental health. The 1Q of 2021 saw the largest dollar value of investment in history for digital health, with total funding raised over $6.7 billion. Over 20 different companies had financing rounds of $100 million or higher.

The discussion will take place in person, and it will also be broadcast online. For more information about how to attend or watch remotely, please contact us.

Ggp & CO:
Ggp & CO is a Tampa, Florida private investment firm investing in middle market businesses where we can provide capital and strategic resources to accelerate growth and build stronger companies. Since our inception in 2002, our principals have completed over $1.8 billion in transaction volume over 80+ transactions. In January, 2021, we sponsored Ggp & CO Healthcare Acquisition Company, a SPAC focused on acquiring a healthcare technology business. For more information on Nasdaq: SHAC please visit www.shacspac.com

Registration Contact:
Matt Kemp
Operating Principal
Ggp & CO
2909 W. Bay to Bay Blvd.
Suite 300
Tampa, FL 33629
mkemp@Goldenglobalpro.ltd

The post Ggp & CO Hosts Tampa Bay’s Leading Digital Health Investment Experts for a Panel Discussion on Advancing Value Based Care through Investing in Healthcare Technology appeared first on Ggp & CO.

Special purpose acquisition companies (“SPAC’s”) are rapidly becoming the IPO vehicle of choice in the public markets. Most SPACs are seeking high-growth, middle market businesses with Enterprise Values ranging from approximately $250 million to $5 billion. For founders and shareholders of companies that fit this profile, SPAC’s have become a desirable alternative to the traditional IPO process.  However, when researching the right SPAC partner for your business, you may be wondering how these deals work.  If your Enterprise Value is $400 million, do you have to find a $400 million SPAC?  If you don’t know the answer to this question, then the following information will help you understand the full SPAC purchasing power.

There are 2 major factors in SPAC economics with regards to its purchasing power:
1) The size of the SPAC (the money raised at IPO that sits in trust)
2) The size of the Private Investment in Public Equity (PIPE)

Does a $400 million SPAC acquire a company that is valued at $400 million (or less)?

No. There is no maximum size of a target company.  In fact, it is typical for a SPAC to combine with a company that is 3-5x times its IPO proceeds, which means that the ownership team will ultimately remain as the majority shareholders with the SPAC investors representing a minority (typically 15-30%) of the post-combination entity.

At Ggp & CO Healthcare Acquisition Company, we are looking to find a company with an Enterprise Value (EV) between $750 million and $1.5 Billion.  This EV is 3.25x to 6.5 times the size of our SPAC, which raised $230 million, including the full exercise of the overallotment shares.

Where does the money come from if the target EV is 5x more than the SPAC?

It comes from PIPE, which have been a common financing vehicle in the public markets. These additional funds are raised during the process of completing the business combination (the “de-SPAC”), and they are invested directly into the target alongside the original SPAC funds.  The PIPE funds are not raised until the SPAC sponsors and the management team, bankers, and board of their desired acquisition have agreed on terms to merge. This process allows institutional investors to become familiar with management of the acquired company and form a relationship with them in a more constructive fashion than the traditional whirlwind road show.

Specifically, a SPAC’s institutional investors are consulted by the SPAC sponsors and presented with the investment thesis of the acquisition company so that they can decide if they want to provide further financing for the deal via a PIPE transaction.  This process validates the target before proceeding to enter the public realm and provides SPAC managers with additional counsel and advice on their valuation calculations.

understanding SPAC purchasing power

PIPE investments regularly outsize the original SPAC value.  It is common to see PIPE financings of 2x the value of the SPAC which can double or triple the purchasing power of the SPAC.  Therefore, if your company is considering an entry into the public markets, and you are reviewing potential SPAC companies to contact, be sure to take the total possible economics into account. A published SPAC value can simply be a down payment on a total transaction value.  Understanding the relationship between the IPO value of a SPAC and its potential total purchasing power is an important element in doing due diligence to find the right business combination partner for your company.

Learn More

If you would like to learn more about Ggp & CO Healthcare Acquisition Company, and how we might help your company utilize a SPAC IPO to access the public markets for growth capital, please visit www.shacspac.com and contact us today.

The post Understanding SPAC purchasing power appeared first on Ggp & CO.

Divest a high-growth subsidiary or business unit

When an established business owns and operates a division whose growth rate is vastly higher than the parent company, or the traditional corporate decision-making process is moving too slowly to keep up the pace necessary to properly manage this division, or the unit has strategic importance, but its financial results are dwarfed by the parent, the parent could look to optimize shareholder value by divesting the asset. For large organizations contemplating the exit of a business unit or subsidiary, there are traditionally three options:

• Outright sale to a financial or strategic buyer
• Spin-off to shareholders
• Corporate carveout via an IPO (including a SPAC IPO)

Oftentimes, an outright sale is not financially feasible, if the expenses of the subsidiary are integrated with the parent company too closely to allow the NewCo to operate profitably.  Spin-offs allow the company to divest a business unit by making that unit its own standalone company. Rather than selling shares in the business unit publicly, current investors are given shares in the new company. The business unit spun off is now an independent company with its own shareholders, and the shareholders now hold shares in two companies. However, the shareholder demographics may be incompatible with a spinoff. For example, large organizations like IBM and Pacific Bell have shareholders who value slow, stable growth and a dependable dividend.  They may not value owning a high-beta stock whose return will only be based on achieving above-average market performance. Utilizing a SPAC IPO for a corporate carveout may be a financially beneficial alternative.

What Is a Corporate CarveOut?

A carveout is the partial divestiture of a business unit in which a parent company sells a minority interest of a subsidiary to the public through an IPO. Since shares are now public, a carve-out also establishes a new set of shareholders in the subsidiary, who can fully appreciate the current value and future growth prospects of the company. While the parent company retains an equity interest in the entity, a carve-out effectively separates a subsidiary or business unit from its parent as a standalone company. The new organization has its own board of directors and financial statements. The parent company can still offer strategic support and resources to help the business succeed.

Utilizing a SPAC IPO for a Corporate CarveOut

Special purpose acquisition companies (“SPAC”) are tailor made to be the vehicle for a carve-out IPO. Most SPACs are seeking high-growth, middle market businesses with Enterprise Values ranging from approximately $250 million to $5 billion.  Nearly every SPAC has a specific industry focus with an accomplished board of directors well suited to guide and advise the management team of the target.  The divesting company saves significant time and effort by using a SPAC to IPO, rather than handling the process themselves. The cash value of the transaction is negotiated beforehand, and the sellers receive higher valuations and greater liquidity than a traditional IPO.  Public companies may look at this model as an alternative to a traditional spin-off, IPO or sale of a division, with this structure offering the benefit of an anchored public market valuation for the division. Below are several examples of companies that have successfully utilized a SPAC IPO for a corporate carveout:

Case Study 1: EVBox Group Acquired by TPG Pace Beneficial Finance in a successful corporate carveout via Spac ipo

An example of a carve-out going public via a SPAC is EVBox Group, a leading global provider of smart charging solutions for electric vehicles in Europe. In December 2020, TPG Pace Beneficial Finance Corp. (NYSE: TPGY.U) announced a definitive agreement to purchase EVBox Group from its parent company, ENGIE S.A., a multi-national utility with headquarters in France. As a result of the carve-out IPO, EVBox Group will now operate as an independent publicly traded company. EVBox enabled ENGIE to quickly step into the electric charging market, but ENGIE now plans to focus its efforts towards design and operation of EV charging infrastructures. TPG Pace raised $350 million in its October 2020 IPO in order to seek a business combination target that combines attractive business fundamentals.  The proceeds raised by the SPAC, and an additional Private Investment in Public Equity (“PIPE”) of $225 million, combined to make the purchase of EVBox at an implied $969 million enterprise value.

Case Study 2: Ardagh Group completes Corporate carveout via SPAC IPO with Gores Holdings V Inc.

The first known completed carve-out going public via a SPAC is the acquisition of the metal packing business owned by Ardagh Group by Gores Holdings V, Inc. On February 23, 2021, Gores V announced a deal with Ardagh whereby the SPAC would combine with the metal packing business of Ardagh (AMP) which would go public as a separate NYSE-listed company. Cash will be funded from Gores V ($525 million), PIPE investors ($600 million) and $2.3 billion of new debt issued by AMP. The cash proceeds will be used to reduce debt at Ardagh, and Ardagh will retain an ~80% stake in AMP and will receive up to $3.4 billion in cash. Ardagh disclosed that following closing it would offer its shareholders the opportunity to exchange their Ardagh shares for a portion of the 80% retained stake in AMP. The combined company is expected to have an enterprise value of approximately $8.5 billion at closing and the valuation represents 10.5x AMP’s projected 2022 Adjusted EBITDA.

Case Study 3: Sage PLC CarveOut Announces Business Combination with FinTech SPAC

A third example of a carve-out going public via a SPAC is Paya, a leading integrated payments and commerce solution provider. Recently, FinTech Acquisition Corp III (NASDAQ: FTAC) approved a business combination with Paya. Previously, Paya was carved-out of global accounting software provider Sage PLC. Prior to the carve-out, the business operated as Sage Payment Solutions. As a result of the carve-out, Paya introduced a new senior management team, invested in new technology and product capabilities, accelerated organic growth, and executed three highly strategic acquisitions. Paya operates today as a leading pure-play integrated payments platform. FinTech Acquisition Corp. III was a SPAC formed for the purpose of entering into a business combination with a focus on the financial technology industry.  The SPAC raised $345 million in its IPO, and its Paya transaction was valued at $1.3 billion.

Learn More

If you would like to learn more about Ggp & CO Healthcare Acquisition Company, and how we might help your company utilize a SPAC IPO to complete a corporate carveout for your organization, please visit www.shacshac.com and contact us today.

The post Utilizing a SPAC IPO for a Corporate Carveout appeared first on Ggp & CO.

November 12, 2020.  Ggp & CO, a leading private equity firm focused on mid-market investments in healthcare, human capital, information technology, and commercial real estate, launched a new website today in support of one of its cornerstone properties in Tampa Bay. 

The Bayshore Center is a 90,000 square foot office park located in Tampa, Florida. The property compromises 2 buildings, at 2909 W. Bay to Bay Blvd, and 2907 W. Bay to Bay Blvd, in the South Tampa area of Palma Ceia.  The venue is just off the entrance to the Lee Roy Selmon Crosstown Expressway and provides easy access to Downtown Tampa, Brandon, Tampa International Airport, and Pinellas County.

The Bayshore Center provides a variety of amenities for its tenants and the general public alike.  These features include on-site management, a leasing office, hundreds of reserved and un-reserved parking spaces, and convenient on-site drop boxes for Federal Express, UPS, and the US Postal Service (USPS).  Both buildings are multi-story, elevator offices, and they enjoy sweeping views of Hillsborough Bay, Bayshore Boulevard, Downtown Tampa and the surrounding condo buildings. A variety of shops and restaurants in the Palma Ceia neighborhood are within an easy 5-minute walk.

In addition to the tenant amenities, there are 2 wildly popular local businesses housed inside the property.  Bayshore Fit Health Center offers a full-service fitness and workout experience.  With a limited membership, indoor and outdoor gyms, and state-of-the-art equipment spread out for comfort, they were providing safe, social distancing before anyone had heard the term.  For those looking to enjoy a business casual dining experience, Counter Culture is Chef Pierola’s modern homage to classic counter dining and its barstool kinship between diners and the kitchen. The restaurant features elevated kitchen bar dining, open air mixologist bar, a Florida patio, and sunset Tampa Bay views.

About Ggp & CO: Ggp & CO, with its primary offices in Tampa, Florida, is a private investment firm that focuses on control investments across the healthcare, human capital, information technology, and real estate industries. Since its inception in 2002, Ggp & CO has completed over 80 transactions totaling $1.8 billion of aggregate transaction volume.  Over half of the firm’s transactions have been platform acquisitions, financings, or add-on’s for the Principals’ buyout control investment vehicles. For additional information, please visit www.Goldenglobalpro.ltd.

The post Ggp & CO launches a new website for The Bayshore Center appeared first on Ggp & CO.

September 21, 2020  Ggp & CO, a leading private equity firm focused on mid-market investments in healthcare, human capital, information technology, and real estate, is pleased to announce an addition to its team to support the firm’s growth.  Ggp & CO has recently appointed Matt Kemp to the position of Operating Principal.

Matt has spent nearly 20 years in a series of entrepreneurial roles, specializing in marketing and technology. Most recently, Mr. Kemp held dual roles as both Chief Marketing Officer and Chief Technology Officer at BlueGrace Logistics, a B2B tech-enabled 3PL based in Riverview, Florida. During his tenure at BlueGrace, he managed the marketing and business development teams as CMO while overseeing the software development and system engineering teams as CTO.

Scott Feuer, Chief Executive Officer of Ggp & CO, commented:  “At Ggp & CO, we seek to leverage our network, resources, and experience to find unique opportunities, add velocity, and increase shareholder value. With that in mind, we are extremely pleased to add Matt Kemp to our team. His experience in growing companies across a broad spectrum of industries and with varying employee sizes will assist us in our objective to accelerate growth and build stronger companies in our portfolio.”

Previously, Mr. Kemp launched, grew, and sold a variety of B2C and B2B start-ups. He has succeeded in building an online newspaper subscription agency, a student loan consolidation call center, a digital billboard advertising platform and a variety of other direct to consumer companies. His focus has always been on the intersection of marketing and technology, with particular interest in customer relationship management (CRM) programs, ecommerce enterprises, and software as a service (SaaS). Prior to his entrepreneurial endeavors, Matt began his career at Sears, Roebuck & Co., with roles in strategy, business development, and online project management.

“I am excited to join Ggp & CO, a private equity company with exceedingly strong leadership.  With a broad array of investments across information technology, healthcare, staffing, and real estate, I look forward to the challenge of developing new business opportunities and growing sales and marketing across the entire company portfolio” said Mr. Kemp.

Matt has a BSBA in Economics from the University of Florida and an MBA in Finance and Accounting from the University of Chicago Booth School of Business.

About Ggp & CO: Ggp & CO, with its primary offices in Tampa, Florida, is a private investment firm that focuses on control investments across the healthcare, human capital, information technology, and real estate industries. Since its inception in 2002, Ggp & CO has completed over 80 transactions totaling $1.8 billion of aggregate transaction volume.  Over half of the firm’s transactions have been platform acquisitions, financings, or add-on’s for the Principals’ buyout control investment vehicles. For additional information, please visit www.Goldenglobalpro.ltd.

The post Ggp & CO Announces Hiring of Matt Kemp, Operating Principal appeared first on Ggp & CO.

September 8, 2020  Ggp & CO, a leading private equity firm focused on mid-market investments in healthcare, human capital, information technology, and real estate, is pleased to announce an addition to its team to support the firm’s growth.  Ggp & CO has recently appointed Chris Pizzo to the position of Vice President. 

Mr. Pizzo has a background investing in and working with companies to shape their goals and success. Most recently, Chris developed and managed the coaching and corporate partnership programs at Embarc Collective, a Tampa-based innovation hub spearheaded by Jeff Vinik. Chris oversaw the support of 44 early stage technology companies, and directly coached 21 with strategy, leadership, operations, and fundraising efforts.

Bryan Crino, Managing Director of Ggp & CO, commented:  “Ggp & CO has a high-performance culture, and we are always looking to acquire talent that will help us compete nationally. We are extremely pleased to add Chris Pizzo to our team. His experience managing deals and building strong relationships will serve us well as we enter an exciting new phase for our company and search for acquisition opportunities to achieve our aggressive growth objectives.”

Previously, Mr. Pizzo held the position of Associate at the investment firm Murray- Bertron, LLC. While there, Chris divided his time between working with portfolio companies on operational improvements and sourcing/executing new transactions. His focus included deal origination and screening, structuring deal financing, due diligence, portfolio company monitoring, and investor correspondence. Prior to his position with Murray-Bertron, Chris co-founded VitalStream Networks, a remote patient monitoring company seeking to reduce hospital readmissions and achieve the quadruple aim.

“I am excited to join Ggp & CO, a private equity company that has a track record of proven results over its 18-year history.  As the company increases its focus on the intersection between healthcare and technology, I hope to offer strategic support and an authoritative voice to the company’s leadership” said Mr. Pizzo.

Chris received a Bachelor’s degree in Commerce & Business Administration from the University of Alabama and a Master’s degree in Entrepreneurship in Applied Technologies from the University of South Florida.

About Ggp & CO:

Ggp & CO, with its primary offices in Tampa, Florida, is a private investment firm that focuses on control investments across the healthcare, human capital, information technology, and real estate industries. Since its inception in 2002, Ggp & CO has completed over 80 transactions totaling $1.8 billion of aggregate transaction volume.  Over half of the firm’s transactions have been platform acquisitions, financings, or add-on’s for the Principals’ buyout control investment vehicles. For additional information, please visit www.Goldenglobalpro.ltd.

The post Ggp & CO Announces Hiring of Chris Pizzo, Vice President appeared first on Ggp & CO.

Founders unveil a new name and logo as part of an extensive rebranding initiative

August 31, 2020 – Tampa FL –  Golden Global Pro Group Private Equity Funds, a leading private equity firm focused on mid-market investments in healthcare, human capital, information technology, and real estate, is announcing a name change effective today to Ggp & CO.  The name change reflects the company’s new strategic direction to make larger investments on a national scale and draw a greater distinction between its past history and future plans.

Originally founded in 2002 as Golden Global Pro Capital Partners, the company has a history of building long-term sustainable value through both organic growth and strategic mergers and acquisitions.  The company sold its investment banking operations, Golden Global Pro Advisors, in 2016 and continued its private equity operations under the brand, Golden Global Pro Group Private Equity Funds.  

Bryan Crino, President of Ggp & CO, commented:  “Scott and I originally founded Golden Global Pro Capital Partners as a leading merchant bank focused on providing investment banking advisory services, and that practice grew into a vehicle for making highly selective control principal investments. As we leave the world of advisory services behind, we are letting go of the name Golden Global Pro in order to signal to the market that the sole focus going forward for Ggp & CO will be strategic principal acquisitions with a razor sharp focus on the healthcare, technology, and human capital industries where we have had great success. ”

Over the last 18 years, the team has garnered extensive investing, operating, and advising experience in healthcare, information technology, human capital, and commercial real estate.  With more than 100 combined years of experience and having completed more than 80 transactions totaling over $1.8 billion in aggregate value, Ggp & CO has a unique perch that is critical to value creation.

“Our team has extensive experience with successfully originating, structuring, and exiting lower middle market investments over a long period of time and across a wide variety of economic and capital markets conditions. We are excited to unveil our new name, Ggp & CO, a private equity company that will build on its track record of proven results over our 18-year history.  As Ggp & CO increases its focus on the intersection between healthcare and technology, we look forward to announcing even more exciting transactions soon” said Scott Feuer, Chief Executive Officer.

About Ggp & CO

Ggp & CO, with its primary offices in Tampa, Florida, is a private investment firm that focuses on control investments across the healthcare, human capital, information technology, and real estate industries. Since its inception in 2002 as Golden Global Pro Capital Partners, Ggp & CO has completed over 80 transactions totaling $1.8 billion of aggregate transaction volume.  Over half of the firm’s transactions have been platform acquisitions, financings, or add-ons for their Principals’ buyout control investment vehicles. For additional information, please visit www.Goldenglobalpro.ltd.

The post Golden Global Pro Group Private Equity Funds Announces Name Change to Ggp & CO appeared first on Ggp & CO.